KR101979836B1 - 칼코부트롤의 제조방법 - Google Patents
칼코부트롤의 제조방법 Download PDFInfo
- Publication number
- KR101979836B1 KR101979836B1 KR1020190000085A KR20190000085A KR101979836B1 KR 101979836 B1 KR101979836 B1 KR 101979836B1 KR 1020190000085 A KR1020190000085 A KR 1020190000085A KR 20190000085 A KR20190000085 A KR 20190000085A KR 101979836 B1 KR101979836 B1 KR 101979836B1
- Authority
- KR
- South Korea
- Prior art keywords
- butrol
- acid
- purity
- exchange resin
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 15
- GCLKDXFGQNCFQW-CTHHTMFSSA-L calcium 2-[4,10-bis(carboxylatomethyl)-7-[(2R,3S)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate hydron Chemical compound [H+].[Ca+2].OC[C@@H](O)[C@@H](CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 GCLKDXFGQNCFQW-CTHHTMFSSA-L 0.000 title claims description 5
- 229950006450 calcobutrol Drugs 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title description 4
- JZNZSKXIEDHOBD-HUUCEWRRSA-N 2-[4,10-bis(carboxymethyl)-7-[(2r,3s)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid Chemical compound OC[C@@H](O)[C@@H](CO)N1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 JZNZSKXIEDHOBD-HUUCEWRRSA-N 0.000 claims abstract description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- 238000002425 crystallisation Methods 0.000 claims description 16
- 230000008025 crystallization Effects 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 6
- 239000003729 cation exchange resin Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000003957 anion exchange resin Substances 0.000 claims description 3
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims description 3
- 229940106681 chloroacetic acid Drugs 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000008121 dextrose Substances 0.000 claims description 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 2
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 claims description 2
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 claims description 2
- ARXKVVRQIIOZGF-UHFFFAOYSA-N 1,2,4-butanetriol Chemical compound OCCC(O)CO ARXKVVRQIIOZGF-UHFFFAOYSA-N 0.000 claims 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 150000003141 primary amines Chemical group 0.000 claims 1
- 125000001453 quaternary ammonium group Chemical group 0.000 claims 1
- 150000003335 secondary amines Chemical group 0.000 claims 1
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- 150000003512 tertiary amines Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 11
- 238000000746 purification Methods 0.000 abstract description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 abstract description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 abstract description 3
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 abstract 2
- 229910052688 Gadolinium Inorganic materials 0.000 description 8
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- ZPDFIIGFYAHNSK-CTHHTMFSSA-K 2-[4,10-bis(carboxylatomethyl)-7-[(2r,3s)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+) Chemical compound [Gd+3].OC[C@@H](O)[C@@H](CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 ZPDFIIGFYAHNSK-CTHHTMFSSA-K 0.000 description 6
- 229960003411 gadobutrol Drugs 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 150000001768 cations Chemical class 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000003795 desorption Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- -1 10 - ((2R, 3S) -1,3,4-trihydroxybutan-2-yl) -1,4,7,10-tetraazacyclodecane- Chemical compound 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- ZPDFIIGFYAHNSK-UHFFFAOYSA-K gadobutrol Chemical compound [Gd+3].OCC(O)C(CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 ZPDFIIGFYAHNSK-UHFFFAOYSA-K 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- QBPPRVHXOZRESW-UHFFFAOYSA-N 1,4,7,10-tetraazacyclododecane Chemical compound C1CNCCNCCNCCN1 QBPPRVHXOZRESW-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- GEKNCWQQNMEIMS-UHFFFAOYSA-N 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane Chemical compound C1OC(C)(C)OCC2OC21 GEKNCWQQNMEIMS-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- AAWOZSYENLKGCT-UHFFFAOYSA-N Cl.N1(CCNCCNCCN1)C(C(CO)O)CO Chemical compound Cl.N1(CCNCCNCCN1)C(C(CO)O)CO AAWOZSYENLKGCT-UHFFFAOYSA-N 0.000 description 1
- 239000002616 MRI contrast agent Substances 0.000 description 1
- HQAQMUMVIFKRSJ-CHWSQXEVSA-N OC[C@H]([C@@H](CO)O)N1N(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 Chemical compound OC[C@H]([C@@H](CO)O)N1N(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 HQAQMUMVIFKRSJ-CHWSQXEVSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (8)
- 사이클렌(1,4,7,10-테트라아자사이클로도데칸)과 4,4-디메틸-3,5,8-트리옥사비사이클로[5,1,0]옥탄을 반응시켜 3-(1,4,7,10-테트라아자사이클로데칸-1-일)부탄-1,2,4-트리올을 얻고, 할로아세트산과 반응시켜 크루드 부트롤을 제조하는 제 1단계;
음이온 교환수지 및 양이온 교환수지를 혼합하여 사용함으로써 상기 크루드 부트롤을 1차 정제하는 제 2단계; 및
1차 정제된 크로드 부트롤을 20% 이상의 물함량을 갖는 메탄올 수용액에서 2차 정제하는 제 3단계를 포함하는,
순도 99% 이상의 부트롤(2, 2', 2''-(10-((2R, 3S)-1,3,4-트리하이드록시부탄-2-일)-1,4,7,10-테트라아자시클로데칸-1,4,7-트리일)트리아세트산)을 얻는 제조방법 - 삭제
- 제 2 항에 있어서, 상기 음이온 교환수지는 4급 암모늄, 3급 암모늄, 3급 아민, 2급 아민, 1급 아민으로 이루어지는 군으로부터 선택되고, 상기 양이온 교환수지는 술폰산기, 카르복실기로 이루어지는 군으로부터 선택되는 것을 특징으로 하는 제조방법
- 제 1 항에 있어서, 할로아세트산은 클로로아세트산, 브로모 아세트산, 요오도 아세트산으로 이루어지는 군으로부터 선택되는 것을 특징으로 하는 제조방법
- 삭제
- 삭제
- 제 1 항에 있어서 결정화 전의 pH가 3.5~4.5인 제조방법
- 제 1 항에 따라 제조된 부트롤과 탄산칼슘을 반응시켜 칼코부트롤을 제조하는 방법
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020190000085A KR101979836B1 (ko) | 2019-01-02 | 2019-01-02 | 칼코부트롤의 제조방법 |
| CN201980087491.9A CN113272284B (zh) | 2019-01-02 | 2019-11-20 | 制备考布曲钙的方法 |
| PCT/KR2019/015962 WO2020141723A1 (ko) | 2019-01-02 | 2019-11-20 | 칼코부트롤의 제조방법 |
| JP2021538471A JP7272710B2 (ja) | 2019-01-02 | 2019-11-20 | カルコブトロールの製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020190000085A KR101979836B1 (ko) | 2019-01-02 | 2019-01-02 | 칼코부트롤의 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR101979836B1 true KR101979836B1 (ko) | 2019-05-21 |
Family
ID=66675345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020190000085A Active KR101979836B1 (ko) | 2019-01-02 | 2019-01-02 | 칼코부트롤의 제조방법 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP7272710B2 (ko) |
| KR (1) | KR101979836B1 (ko) |
| CN (1) | CN113272284B (ko) |
| WO (1) | WO2020141723A1 (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11588339B2 (en) | 2021-02-03 | 2023-02-21 | Jason Watson | Combination charging cable and hair tie assembly |
| CN119143689B (zh) * | 2024-11-15 | 2025-05-30 | 苏州美诺医药科技有限公司 | 考布曲钙和其中间体的制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101057939B1 (ko) | 2009-11-04 | 2011-08-18 | 바이엘 파마 악티엔게젤샤프트 | 칼코부트롤의 제조 방법 |
| KR101693400B1 (ko) | 2014-09-17 | 2017-01-05 | 에스티팜 주식회사 | 칼코부트롤의 제조방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4218744C2 (de) * | 1992-06-04 | 1997-11-06 | Schering Ag | Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe |
| CN103613557B (zh) * | 2013-10-18 | 2015-07-29 | 武汉利宝瑞医药科技有限公司 | 一种磁共振成像对比剂钆布醇的制备方法 |
| KR101653064B1 (ko) | 2014-12-26 | 2016-09-09 | 에스티팜 주식회사 | 가도부트롤의 제조방법 |
-
2019
- 2019-01-02 KR KR1020190000085A patent/KR101979836B1/ko active Active
- 2019-11-20 WO PCT/KR2019/015962 patent/WO2020141723A1/ko not_active Ceased
- 2019-11-20 JP JP2021538471A patent/JP7272710B2/ja active Active
- 2019-11-20 CN CN201980087491.9A patent/CN113272284B/zh active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101057939B1 (ko) | 2009-11-04 | 2011-08-18 | 바이엘 파마 악티엔게젤샤프트 | 칼코부트롤의 제조 방법 |
| KR101693400B1 (ko) | 2014-09-17 | 2017-01-05 | 에스티팜 주식회사 | 칼코부트롤의 제조방법 |
Non-Patent Citations (2)
| Title |
|---|
| Inorg. Chem. 1997, 36, 6086-6093 |
| Inorganic chemistry, 1997, v.36, no.26, pp.6086-6093* * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022515893A (ja) | 2022-02-22 |
| JP7272710B2 (ja) | 2023-05-12 |
| WO2020141723A1 (ko) | 2020-07-09 |
| CN113272284B (zh) | 2024-06-21 |
| CN113272284A (zh) | 2021-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU624130B2 (en) | Gabapentin monohydrate and a process for producing same | |
| JP2023153826A (ja) | Dota合成 | |
| KR101979836B1 (ko) | 칼코부트롤의 제조방법 | |
| KR101832027B1 (ko) | 폴리아미노카르복실레이트의 정제 공정 | |
| CN102924311B (zh) | 一种l-天门冬氨酸-l-鸟氨酸盐的制备方法 | |
| CN108299322A (zh) | 一种制备高纯度钆布醇的方法 | |
| CA2801968A1 (en) | Process for preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid and use for production of primovist® | |
| US11192864B2 (en) | Method for producing calcobutrol | |
| CN101475578A (zh) | 一种氟氯西林钠化合物及其制备方法 | |
| KR101971435B1 (ko) | 가도부트롤 중간체 및 이를 이용한 가도부트롤의 제조 방법 | |
| EP4043472B1 (en) | Method for preparing disodium 5'-guanylate heptahydrate crystal | |
| RU2779668C1 (ru) | Способ получения калькобутрола | |
| US11319294B2 (en) | Method for manufacturing calteridol | |
| EP3875453A1 (en) | Method for manufacturing calcobutrol | |
| KR20200022648A (ko) | 가도부트롤의 제조방법 | |
| TR2021010179T2 (tr) | Kalkobutrol hazirlamaya yöneli̇k yöntem | |
| JPH0317096A (ja) | タウロウルソデオキシコール酸二水塩の製造方法 | |
| WO2013159283A1 (zh) | 一种制备(s)−奥拉西坦的方法 | |
| US20210252037A1 (en) | Process for the preparation of hydroxocobalamin hydrochloride | |
| JPS58188862A (ja) | N−アシルカルノシンの製造法 | |
| CN107129437A (zh) | 4-[(2-氯乙基-2-羟乙基)氨基-]-l-苯丙氨酸盐酸盐的制备方法与应用 | |
| CN113087680A (zh) | Dota晶型及其制备方法 | |
| JPS60146897A (ja) | ビオプテリンの精製法 | |
| JP2000239259A (ja) | 2−ピペラジンカルボン酸の製造法 | |
| JPS61229880A (ja) | アミノ化フタライド−イソキノリン類の製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20190102 |
|
| PA0201 | Request for examination | ||
| PA0302 | Request for accelerated examination |
Patent event date: 20190102 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination |
|
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190321 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20190429 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20190513 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20190513 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20220215 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20230216 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20250210 Start annual number: 7 End annual number: 7 |